关注
Parham Jabbarzadeh Kaboli (ORCID: 0000-0002-4157-7901)
Parham Jabbarzadeh Kaboli (ORCID: 0000-0002-4157-7901)
其他姓名Parham J. Kaboli
在 mail.cmu.edu.tw 的电子邮件经过验证 - 首页
标题
引用次数
引用次数
年份
Targets and mechanisms of berberine, a natural drug with potential to treat cancer with special focus on breast cancer
P Jabbarzadeh Kaboli, A Rahmat, P Ismail, KH Ling
European Journal of Pharmacology 740, 584-595, 2014
1592014
MicroRNA-based therapy and breast cancer: A comprehensive review of novel therapeutic strategies from diagnosis to treatment
PJ Kaboli, A Rahmat, P Ismail, KH Ling
Pharmacological research 97, 104-121, 2015
1502015
Akt-targeted therapy as a promising strategy to overcome drug resistance in breast cancer–A comprehensive review from chemotherapy to immunotherapy
PJ Kaboli, F Salimian, S Aghapour, S Xiang, Q Zhao, M Li, X Wu, F Du, ...
Pharmacological research 156, 104806, 2020
1212020
m1A regulated genes modulate PI3K/AKT/mTOR and ErbB pathways in gastrointestinal cancer
Y Zhao, Q Zhao, PJ Kaboli, J Shen, M Li, X Wu, J Yin, H Zhang, Y Wu, ...
Translational oncology 12 (10), 1323-1333, 2019
1172019
Engineered TCR-T cell immunotherapy in anticancer precision medicine: pros and cons
Q Zhao, Y Jiang, S Xiang, PJ Kaboli, J Shen, Y Zhao, X Wu, F Du, M Li, ...
Frontiers in immunology 12, 658753, 2021
972021
An ethnobotanical survey of medicinal plants used by indigenous people in Zangelanlo district, Northeast Iran
MS Amiri, P Jabbarzadeh, M Akhondi
J Med Plants Res 6 (5), 749-753, 2012
732012
Identification of prognostic genes in the tumor microenvironment of hepatocellular carcinoma
S Xiang, J Li, J Shen, Y Zhao, X Wu, M Li, X Yang, PJ Kaboli, F Du, ...
Frontiers in immunology 12, 653836, 2021
612021
Antitumor effects of berberine against EGFR, ERK1/2, P38 and AKT in MDA-MB231 and MCF-7 breast cancer cells using molecular modelling and in vitro study
P Jabbarzadeh Kaboli, MPY Leong, P Ismail, KH Ling
Pharmacological Reports 71, 13-23, 2019
552019
Conditional reprogramming: next generation cell culture
X Wu, S Wang, M Li, J Li, J Shen, Y Zhao, J Pang, Q Wen, M Chen, B Wei, ...
Acta Pharmaceutica Sinica B 10 (8), 1360-1381, 2020
532020
Metagenome analysis of intestinal bacteria in healthy people, patients with inflammatory bowel disease and colorectal cancer
Y Ma, Y Zhang, H Jiang, S Xiang, Y Zhao, M Xiao, F Du, H Ji, PJ Kaboli, ...
Frontiers in cellular and infection microbiology 11, 599734, 2021
502021
A review of Penthorum chinense Pursh for hepatoprotection: traditional use, phytochemistry, pharmacology, toxicology and clinical trials
A Wang, M Li, H Huang, Z Xiao, J Shen, Y Zhao, J Yin, PJ Kaboli, J Cao, ...
Journal of ethnopharmacology 251, 112569, 2020
492020
Characterization of chemical composition and prebiotic effect of a dietary medicinal plant Penthorum chinense Pursh
J Yin, W Ren, B Wei, H Huang, M Li, X Wu, A Wang, Z Xiao, J Shen, ...
Food chemistry 319, 126568, 2020
462020
Targets and mechanisms of sulforaphane derivatives obtained from cruciferous plants with special focus on breast cancer–contradictory effects and future perspectives
PJ Kaboli, MA Khoshkbejari, M Mohammadi, A Abiri, R Mokhtarian, ...
Biomedicine & Pharmacotherapy 121, 109635, 2020
462020
CD44 inhibition attenuates EGFR signaling and enhances cisplatin sensitivity in human EGFR wild‑type non‑small‑cell lung cancer cells
J Yin, H Zhang, X Wu, Y Zhang, J Li, J Shen, Y Zhao, Z Xiao, L Lu, ...
International journal of molecular medicine 45 (6), 1783-1792, 2020
402020
Long non-coding RNAs: potential biomarkers and targets for hepatocellular carcinoma therapy and diagnosis
D Yuan, Y Chen, X Li, J Li, Y Zhao, J Shen, F Du, PJ Kaboli, M Li, X Wu, ...
International Journal of Biological Sciences 17 (1), 220, 2021
342021
Shedding light on triple-negative breast cancer with Trop2-targeted antibody-drug conjugates
PJ Kaboli, S Shabani, S Sharma, MP Nasr, H Yamaguchi, MC Hung
American journal of cancer research 12 (4), 1671, 2022
322022
Chemoresistance in breast cancer: PI3K/Akt pathway inhibitors vs the current chemotherapy
PJ Kaboli, S Imani, M Jomhori, KH Ling
American Journal of Cancer Research 11 (10), 5155, 2021
322021
Natural killer cells as a double-edged sword in cancer immunotherapy: A comprehensive review from cytokine therapy to adoptive cell immunotherapy
Y Wu, J Li, PJ Kaboli, J Shen, X Wu, Y Zhao, H Ji, F Du, Y Zhou, Y Wang, ...
Pharmacological research 155, 104691, 2020
312020
Molecular modeling, dynamics simulations, and binding efficiency of berberine derivatives: A new group of RAF inhibitors for cancer treatment
P Jabbarzadeh Kaboli, P Ismail, KH Ling
PLoS One 13 (3), e0193941, 2018
312018
Comprehensive understanding of B7 family in gastric cancer: expression profile, association with clinicopathological parameters and downstream targets
D Li, S Xiang, J Shen, M Xiao, Y Zhao, X Wu, F Du, H Ji, M Li, Q Zhao, ...
International journal of biological sciences 16 (4), 568, 2020
302020
系统目前无法执行此操作,请稍后再试。
文章 1–20